profile-img
JAMA Ophthalmology

@JAMAOphth

JAMA Ophthalmology is a member of the JAMA Network, a consortium of peer-reviewed, general medical and specialty publications.

calendar_today07-07-2009 21:15:10

12,6K Tweets

18,8K Followers

168 Following

JAMA Ophthalmology(@JAMAOphth) 's Twitter Profile Photo

In study participants with diabetic macular edema, those in the brolucizumab arm had some superior anatomic improvements; no clinically meaningful differences in visual outcomes were noted between the brolucizumab and aflibercept arms. ja.ma/40Eb9ul

In study participants with diabetic macular edema, those in the brolucizumab arm had some superior anatomic improvements; no clinically meaningful differences in visual outcomes were noted between the brolucizumab and aflibercept arms. ja.ma/40Eb9ul
account_circle